We are live on ! Find out more
BCM

BML Capital Management Portfolio holdings

AUM $156M
1-Year Est. Return 129.82%
This Fund
S&P 500
This Quarter Est. Return
+23.16%
1 Year Est. Return
+129.82%
3 Year Est. Return
+394.84%
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$109M
AUM Growth
-$23M
Cap. Flow
-$12.8M
Cap. Flow %
-11.73%
Top 10 Hldgs %
93.88%
Holding
28
New
4
Increased
4
Reduced
5
Closed
8

Top Buys

Rank Stock Value
1
TIL icon
Instil Bio
TIL
+$2.81M
2
TGT icon
Target
TGT
+$985K
3
PMVP icon
PMV Pharmaceuticals
PMVP
+$404K
4
ARVN icon
Arvinas
ARVN
+$379K
5
KZR
Kezar Life Sciences
KZR
+$351K

Top Sells

Rank Stock Value
1
EPIX
ESSA Pharma
EPIX
+$7.18M
2
MIST icon
Milestone Pharmaceuticals
MIST
+$2.2M
3
ELEV
Elevation Oncology
ELEV
+$2.16M
4
IMA
ImageneBio Inc
IMA
+$2.03M
5
CNTB
Connect Biopharma Holdings
CNTB
+$981K

Sector Composition

Rank Sector Weight
1 Healthcare 97.71%
2 Technology 0.99%
3 Consumer Staples 0.82%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
TSBX
26
DELISTED
Turnstone Biologics
TSBX
– –
-1,103,386
Closed -$396K
TSLA icon
27
PUT
Tesla
TSLA
$1.18T
– –
-200
Closed -$1.65M
VRCA icon
28
Verrica Pharmaceuticals
VRCA
$89M
– –
-17,465
Closed -$92.6K
1
2

Similar funds

AIS
Accredited Investor Services St. Cloud, Minnesota $156M AUM 21.61% 1-Year Est. Return
BWM
BNB Wealth Management Silver Spring, Maryland $156M AUM
CFG
Cornerstone Financial Group Omaha, Nebraska $156M AUM 12% 1-Year Est. Return
BCM
Bluefin Capital Management New York $156M AUM 18.47% 1-Year Est. Return
PMSA
Patrick M. Sweeney & Associates Libertyville, Illinois $156M AUM 19.16% 1-Year Est. Return
GSWA
Good Steward Wealth Advisors Clarksville, Tennessee $156M AUM 13.06% 1-Year Est. Return
SPM
Summit Portfolio Management Las Vegas, Nevada $155M AUM
MCA
McGuire Capital Advisors Bethany, Oklahoma $156M AUM

BML Capital Management's Q3 2025 Portfolio in Review

As of Q3 2025, BML Capital Management held 28 positions worth $109M, down 17% from $132M the previous quarter. Its ten largest holdings account for 94% of the portfolio.

BML Capital Management withdrew a net $12.8M in Q3 2025, closing 8 positions and reducing 5 holdings. Its most notable exit was ESSA Pharma, an estimated $7.18M position sold in full.

By sector, the portfolio is most concentrated in Healthcare at 98% of assets, down from 98% a quarter earlier, followed by Technology and Consumer Staples.

Against the trend, BML Capital Management opened a new position in Target worth $897K.

  • BML Capital Management's largest Q3 2025 buy was Target: 10,000 shares worth $897K.
  • BML Capital Management added most to Instil Bio in Q3 2025, an estimated $2.81M increase.
  • BML Capital Management's biggest Q3 2025 reduction was ImageneBio Inc, cutting an estimated $2.03M.
  • BML Capital Management fully exited ESSA Pharma in Q3 2025, selling an estimated $7.18M.
  • BML Capital Management's ten largest holdings make up 94% of its $109M portfolio in Q3 2025.
  • BML Capital Management opened 4 new positions and closed 8 in Q3 2025.
  • BML Capital Management's portfolio value fell 17% quarter-over-quarter to $109M.

Based on BML Capital Management's 13F filing for Q3 2025, filed 10 Nov 2025.